Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05067816 · ClinicalTrials.gov registry record · NA

Med-South Lifestyle Program Implementation Study

A NA study of Healthy Lifestyle, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
368
Enrollment target
1
Study location

NCT05067816 is a NA study of Healthy Lifestyle that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 368 participants, above the 213-participant average among 16 other Healthy Lifestyle trials with a reported enrollment target (73% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05067816, a NA study of Healthy Lifestyle, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
368 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the processes by which a previously proven lifestyle intervention (the Med-South Lifestyle Program) can most effectively and efficiently be translated into public health and clinical practice to positively impact chronic disease risk reduction among mostly minority, rural, and medically underserved populations.

Conditions Studied

Interventions

  • BEHAVIORAL Med-South Lifestyle Program

Study Locations (1)

North Carolina

  • UNC Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 368 participants
Start Date 2021-10-26
Est. Completion 2024-02-01
Phase NA

What the Registry Record Tells You About NCT05067816

The ClinicalTrials.gov registry entry for NCT05067816 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 368 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 213-participant average among 16 other Healthy Lifestyle trials with a reported enrollment target (73% higher). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Lifestyle appearing as the primary indexed condition, and to 1 intervention - of which Med-South Lifestyle Program is the first listed.

NCT05067816 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05067816 about?

NCT05067816 is a clinical study titled "Med-South Lifestyle Program Implementation Study". The purpose of this study is to determine the processes by which a previously proven lifestyle intervention (the Med-South Lifestyle Program) can most effectively and efficiently be translated into public health and clinical practice to positively impact chronic disease risk reduction among mostly m...

What is the current status of trial NCT05067816?

This trial is currently completed. It is a NA study. The enrollment target is 368 participants. The study started on 2021-10-26. Estimated completion is 2024-02-01.

What conditions does trial NCT05067816 study?

This clinical trial studies the following conditions: Healthy Lifestyle.

What interventions are being tested in trial NCT05067816?

The interventions under investigation include: Med-South Lifestyle Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05067816?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05067816 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Lifestyle

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.